Search by Drug Name or NDC
NDC 62135-0189-41 ALBUTEROL SULFATE 2 mg/5mL Details
ALBUTEROL SULFATE 2 mg/5mL
ALBUTEROL SULFATE is a ORAL SYRUP in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is ALBUTEROL SULFATE.
MedlinePlus Drug Summary
Albuterol is used to prevent and treat wheezing, difficulty breathing, chest tightness, and coughing caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways). Albuterol is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
Related Packages: 62135-0189-41Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Albuterol
Product Information
NDC | 62135-0189 |
---|---|
Product ID | 62135-189_06d28eff-ac4e-5b9b-e063-6294a90a1497 |
Associated GPIs | 44201010101205 |
GCN Sequence Number | 005032 |
GCN Sequence Number Description | albuterol sulfate SYRUP 2 MG/5 ML ORAL |
HIC3 | J5D |
HIC3 Description | BETA-ADRENERGIC AGENTS |
GCN | 22780 |
HICL Sequence Number | 002073 |
HICL Sequence Number Description | ALBUTEROL SULFATE |
Brand/Generic | Generic |
Proprietary Name | ALBUTEROL SULFATE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Albuterol Sulfate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SYRUP |
Route | ORAL |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/5mL |
Substance Name | ALBUTEROL SULFATE |
Labeler Name | Chartwell RX, LLC |
Pharmaceutical Class | Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077788 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0189-41 (62135018941)
NDC Package Code | 62135-189-41 |
---|---|
Billing NDC | 62135018941 |
Package | 120 mL in 1 CONTAINER (62135-189-41) |
Marketing Start Date | 2022-06-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |